The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma. - Wikidata - awgldk - TriplyDB

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

http://www.wikidata.org/entity/Q53947641

about

Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to Bone The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro.Regulator of G protein signaling 1 suppresses CXCL12-mediated migration and AKT activation in RPMI 8226 human plasmacytoma cells and plasmablasts.Pathogenesis beyond the cancer clone(s) in multiple myeloma.SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II.Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.Chemokines in multiple myeloma Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model Oncolytic virotherapy for multiple myeloma: past, present, and future.3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells.Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma.Cell Trafficking in Multiple Myeloma Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.

P2860

Q21285161-ABAFE83C-7D53-4E86-B592-35A79D74D3C0 Q24605861-9F8FBCD8-4FB8-4C6D-BF57-76E6E7730C87 Q26740710-6397EE61-8675-4255-B285-BB0C961DB662 Q28244041-CDD2CF35-75BB-4D01-BAB3-65215F840983 Q28476755-43EA14ED-D055-4856-8BC6-46CDBE4DC644 Q30487339-A78D9359-CBD2-4EB5-A462-DA4C34506441 Q30488936-C44D5314-2850-411F-BA6D-620EEEC676C9 Q33710200-495ACADE-CD95-47C8-9349-6D4537F7BC62 Q34155848-F5222B53-FEE7-4868-A7CE-B69D9D002C46 Q34494776-1466D2E2-A29A-42F4-8545-AB9F1D19B965 Q35510866-424C8491-0CF8-45DB-9EC7-D2677401288D Q35607266-09D716CA-6076-401A-A13D-2BAFB598D3A5 Q35680177-38EAAC05-574B-4B17-8441-DDBFDC41B725 Q35734509-794AF35E-9ED2-4496-B18F-A66864464DA3 Q35750964-749F4B6B-5B7F-4F74-8B07-46B2339D126E Q35776423-6ED157EF-4F67-44BA-80EB-C4CC11896434 Q35847913-F30BC196-DD3E-4D52-AD26-F7ABB5F2FB3A Q36057606-863C7EC1-ADF5-472E-971E-C982C142B0C0 Q36596949-0A6510BE-C5C0-45D0-9DC2-51E4CF259747 Q37575786-7BBEFC21-36E4-498A-A8D2-B728D742F7AD Q37694678-30F5D348-EE33-4BAC-9313-21A1A67D8B8C Q37718435-57E91298-4314-4AE1-9E83-6B01F3790B27 Q38803056-52177B83-BA60-4EED-BED6-9534B7EA0DFC Q38832888-D565A64B-F87C-4740-B8CD-6D159EC13E31 Q39705098-3B186EC2-B06A-4B5E-B7B4-760FD7D8B9B7 Q40328451-CD012EB5-A659-49EE-95C2-11418CB4FF09 Q40440440-4C275117-7F1B-464C-A3DC-105556322355 Q41770950-80CA29E0-27F2-46D7-8983-10BC27B98531 Q41839288-16DDEE19-5276-4DCB-B31C-80B69302EE85 Q42093258-4216D84F-7B89-4536-A35E-D51B7F01277E Q42146660-3E87CC35-C732-4914-A63A-DB0A39AA0B3A Q42399819-69C17380-2FFE-4F58-A076-EF753FBD10DE

P2860

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

http://www.wikidata.org/entity/Q53947641

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

@en

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

@nl

type

label

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

@en

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

@nl

prefLabel

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

@en

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

@nl

P1433

Q53947641-591F7E5B-E756-4036-900B-C066822CAD09

P1476

Q53947641-40F6CE1B-155C-4477-B95F-F32B1483B0D2

P2093

Q53947641-62DEED1E-AD9D-47DC-B19A-36C188489879

Q53947641-989DA139-CE17-4955-9BEE-9B9F1E806F6A

Q53947641-AFC9EEE7-EBF8-48D9-B774-647C2DEE32B6

Q53947641-C01057B3-49CC-4361-9B9D-11BFFDCFCD2D

Q53947641-C4E407BB-F75E-4595-B7E2-4A2E16EBB319

Q53947641-C9D867DD-C684-4388-A324-1122ADABF631

Q53947641-F6D5C785-F99C-4A82-B219-FD0D06E75DBC

P304

Q53947641-62E3FA5A-694A-4960-BAF8-2A2C9E549BDC

P31

Q53947641-90EA6EC1-6B28-4C19-8815-B2FCE3969234

P433

Q53947641-95FD4BD1-8983-4631-A6A0-BFD302FF1BD5

P478

Q53947641-D8F82D22-E7EF-4C33-9409-A9329B7C3CCC

P50

Q53947641-4778568B-E69C-451C-82E3-A53D0887447B

Q53947641-C42C5DF9-2661-4853-A9BF-674BEEC048B3

P577

Q53947641-F67C3290-1B18-41ED-BD81-AAB98C4C6C25

P698

Q53947641-E8A92154-F3CC-4E7B-B306-AF61D7D76E4C

P1433

Molecular Cancer Therapeutics

P1476

The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma

@en

P2093

Deepak Gupta

http://www.w3.org/2001/XMLSchema#string

Dharminder Chauhan

http://www.w3.org/2001/XMLSchema#string

Klaus Podar

http://www.w3.org/2001/XMLSchema#string

Masaharu Akiyama

http://www.w3.org/2001/XMLSchema#string

Nikhil Munshi

http://www.w3.org/2001/XMLSchema#string

Teru Hideshima

http://www.w3.org/2001/XMLSchema#string

Toshiaki Hayashi

http://www.w3.org/2001/XMLSchema#string

P304

539-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth C Anderson

Paul G Richardson

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12479272

http://www.w3.org/2001/XMLSchema#string